Implementation of Bright Light Therapy ID

Condition(s) studied

Investigational drug(s) / intervention(s)

Bright light therapy: for 2 weeks the patient will take place for a 10.000lux lamp for 20-30 minutes.

Study summary

Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT is applicable in this group and seems promising in terms of reducing depressive symptoms, without serious side effects.

In part 1 of this project we investigate the implementation of BLT at Amarant. We will take the lessons learned into part 2 of this project: the implementation of BLT at Abrona. We will evaluate this process and the outcomes.

Eligibility

Primary outcome measure(s)

• acceptability — three times during study, 3-4 months in between
  Acceptability (Proctor et al., 2011) is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. This will be measured by interviews.
• appropriateness — three times during study, 3-4 months in between
  Appropriateness (Proctor et al., 2011) is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. This will be measured by interviews.
• feasibility of the intervention — three times during study, 3-4 months in between
  Feasibility (Proctor et al., 2011) is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. This will be measured by interviews.
• fidelity — three times during study, 3-4 months in between
  Fidelity (Proctor et al., 2011) is defined as the degree to which an intervention was implemented as it was prescribed in the original protocol or as it was intended by the program developers. This will be measured by interviews and by case report study.
• strategies — three times during study, 3-4 months in between
  Implementation strategies are methods to enhance the adoption, implementation and sustainability of a policy or intervention. This will be studied with interview data and logs.
• Determinants — three times during study, 3-4 months in between
  Barriers and facilitators to BLT, measured by interviews using the Consolidated Framework for Implementation Research (CFIR, Damschroder et al., 2009)

Trial sites (1)

More Erasmus Medical Center trials in the Netherlands

Other trials for the same condition